A health worker inoculates a woman with a booster dose of COVID-19 vaccine in Surakarta, Central Java, Indonesia, March 22, 2022. Indonesia's National Agency of Drug and Food Control has approved the use of the Sinopharm COVID-19 vaccine as a booster or the third dose for people aged over 18, the agency's head Penny Lukito said on Tuesday. Currently, Indonesia has six booster vaccines, namely Sinovac, AstraZeneca, Pfizer, Moderna, Janssen, and Sinopharm. (Photo by Bram Selo/Xinhua)
JAKARTA, March 22 (Xinhua) -- Indonesia on Tuesday confirmed 7,464 new COVID-19 cases, raising its tally of infections to 5,974,646, the Health Ministry said.
According to the ministry, the death toll from COVID-19 in the country rose by 170 to 154,062, while 29,084 more people recovered from the disease during the past 24 hours, bringing the total number of recoveries to 5,639,029.
Indonesia's National Agency of Drug and Food Control has approved the use of the Sinopharm COVID-19 vaccine as a booster or the third dose for people aged over 18, the agency's head Penny Lukito said on Tuesday.
Currently, Indonesia has six booster vaccines, namely Sinovac, AstraZeneca, Pfizer, Moderna, Janssen, and Sinopharm.
As the Indonesian government is accelerating its national vaccination programs to curb the spread of the virus, more than 194.90 million people have received their first doses of vaccines, while over 155.39 million have taken the second doses.
Aiming to fully vaccinate 208.26 million people in the country, the government has administered over 367.86 million doses, including the third booster jabs. ■
A health worker inoculates a woman with a booster dose of COVID-19 vaccine in Surakarta, Central Java, Indonesia, March 22, 2022. Indonesia's National Agency of Drug and Food Control has approved the use of the Sinopharm COVID-19 vaccine as a booster or the third dose for people aged over 18, the agency's head Penny Lukito said on Tuesday. Currently, Indonesia has six booster vaccines, namely Sinovac, AstraZeneca, Pfizer, Moderna, Janssen, and Sinopharm. (Photo by Bram Selo/Xinhua)
A health worker inoculates a woman with a booster dose of COVID-19 vaccine in Surakarta, Central Java, Indonesia, March 22, 2022. Indonesia's National Agency of Drug and Food Control has approved the use of the Sinopharm COVID-19 vaccine as a booster or the third dose for people aged over 18, the agency's head Penny Lukito said on Tuesday. Currently, Indonesia has six booster vaccines, namely Sinovac, AstraZeneca, Pfizer, Moderna, Janssen, and Sinopharm. (Photo by Bram Selo/Xinhua)
